Avidity Biosciences Inc
RNA
Market Cap$3.78B
Close$
$-1.55
104.9% downside
Current Fair Value
104.9% downsideOvervalued by 104.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.78 Billion |
|---|---|
| Enterprise Value | $3.55 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.89 |
| Beta | 0.95 |
| Outstanding Shares | 129,232,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.98 |
|---|---|
| PEG | -16.11 |
| Price to Sales | - |
| Price to Book Ratio | 3.14 |
| Enterprise Value to Revenue | 397.34 |
| Enterprise Value to EBIT | -8.19 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data